Welcome to our dedicated page for So-Young Intl news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young Intl stock.
So-Young International Inc. reports on its China aesthetic treatment platform, which connects consumers with online services and offline treatments through digital access points and branded aesthetic centers. Company updates cover curated treatment information, online reservations, aesthetic treatment services, and the development, production and distribution of optoelectronic medical equipment and injectable products.
Recurring news themes include quarterly and annual results, branded center expansion, platform transaction activity, treatment visits, active users, member activity, and operating performance across medical aesthetics services. So-Young also reports foreign-issuer and ADS-related matters, including annual Form 20-F filing announcements and completed Nasdaq listing compliance updates.
So-Young (Nasdaq: SY) reported unaudited Q1 2026 results. Total revenue rose 45.6% year-over-year to RMB432.8 million, led by aesthetic treatment services revenue of RMB282.4 million, up 185.8% and above guidance.
Net loss attributable to the company widened to RMB49.2 million. Verified treatment visits and users more than doubled, and 41 of 54 branded aesthetic centers were profitable, with 48 generating positive quarterly operating cash flow. Q2 2026 aesthetic treatment revenue is guided to grow over 112% year-over-year.
So-Young (NASDAQ:SY), a leading aesthetic treatment platform in China, will release its Q1 2026 financial results before U.S. markets open on May 22, 2026.
Management will host an earnings conference call at 7:30 AM U.S. Eastern Time, with live and archived webcasts available on the investor relations website.
So-Young International (Nasdaq: SY) filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the SEC on April 23, 2026. The annual report, including audited consolidated financial statements, is available on the company's investor relations website.
Shareholders and ADS holders may request a free hard copy by contacting ir@soyoung.com.
So-Young (Nasdaq: SY) reported unaudited Q4 and full-year 2025 results on March 25, 2026. Q4 revenue rose to RMB460.7M (US$65.9M), driven by branded aesthetic centers; Q4 net loss improved to RMB108.8M from RMB607.6M a year earlier. Fiscal 2025 revenue was RMB1,523.4M; net loss was RMB242.3M. The company extended a US$25M share repurchase program through March 31, 2027 and disclosed 49 branded centers, with 25 profitable in Q4.
So-Young (NASDAQ: SY) will report fourth quarter and full year 2025 financial results before U.S. markets open on March 25, 2026. Management will host an earnings conference call on March 25, 2026 at 7:30 AM ET (7:30 PM Beijing/Hong Kong).
Telephone dial-ins, replay numbers, passcodes, and a live/archived webcast at http://ir.soyoung.com are provided for investors and analysts.
So-Young (Nasdaq: SY) reported unaudited Q3 2025 results on November 17, 2025. Total revenue was RMB386.7 million (US$54.3M), up 4.0% year‑over‑year. Aesthetic treatment services revenue rose to RMB183.6 million (US$25.8M), a 304.6% increase from Q3 2024 and above guidance.
The company operated 39 branded aesthetic centers at quarter end, with over 89,800 verified treatment visits and 194,700 treatments in the quarter. Active users exceeded 130,000. 20 centers reached profitability and 29 centers produced positive quarterly operating cash flow.
Q3 net loss attributable to So-Young was RMB64.3 million (US$9.0M); non-GAAP net loss was RMB61.6 million (US$8.7M). Cash and equivalents were RMB942.8 million. Guidance for Q4 2025 aesthetic treatment revenue is RMB216.0–226.0 million (165.8%–178.1% YoY increase).
So-Young (NASDAQ: SY) will report third quarter 2025 financial results for the period ended September 30, 2025 before U.S. markets open on November 17, 2025.
Management will host an earnings conference call on November 17, 2025 at 7:00 AM ET (8:00 PM Beijing/Hong Kong time). Telephone replay will be available from two hours after the call through 23:59 ET on November 24, 2025. A live and archived webcast will be available at http://ir.soyoung.com.
So-Young International Inc. (Nasdaq: SY), China's leading aesthetic treatment platform, reported Q2 2025 financial results showing mixed performance. Total revenues decreased 7.0% to RMB378.7 million (US$52.9 million) compared to Q2 2024. The company reported a net loss of RMB36.0 million (US$5.0 million), contrasting with a net income of RMB18.9 million in Q2 2024.
Notable highlights include aesthetic treatment services revenues surging 426.1% to RMB144.4 million, becoming the largest revenue contributor for the first time. The company now operates 29 branded aesthetic centers across nine major Chinese cities, with 25 centers achieving positive monthly operating cash flow. The number of verified treatment visits reached 67,400, with over 154,500 verified paid aesthetic treatments performed.
For Q3 2025, So-Young expects aesthetic treatment services revenues between RMB150.0-170.0 million, representing 230.5-274.6% year-over-year growth.
So-Young International Inc. (NASDAQ: SY), China's leading aesthetic treatment platform, reported Q2 2025 financial results with total revenues of RMB378.7 million (US$52.9 million), down 7.0% year-over-year. The company's aesthetic treatment services revenue surged 426.1% to RMB144.4 million, becoming the largest revenue contributor for the first time.
The company now operates 29 branded aesthetic centers across 9 major Chinese cities, with 25 centers achieving positive monthly operating cash flow. Key operational metrics showed significant growth, with verified treatment visits reaching 67,400 and active users exceeding 100,400. However, So-Young reported a net loss of RMB36.0 million, compared to a net income of RMB18.9 million in Q2 2024.
For Q3 2025, So-Young expects aesthetic treatment services revenues between RMB150.0-170.0 million, representing 230.5-274.6% year-over-year growth.
[ "Aesthetic treatment services revenue grew 426.1% year-over-year to RMB144.4 million", "25 out of 29 branded aesthetic centers achieved positive monthly operating cash flow", "Verified treatment visits increased significantly to 67,400 from 14,000 year-over-year", "Active users grew to 100,400 from 16,000 in the corresponding period", "Strong Q3 2025 guidance projecting 230.5-274.6% growth in aesthetic treatment services" ]So-Young International (NASDAQ: SY), China's leading aesthetic treatment platform, will release its Q2 2025 financial results on August 15, 2025, before U.S. markets open.
The company will host an earnings conference call on August 15, 2025, at 7:30 AM ET (7:30 PM Beijing/Hong Kong Time). A telephone replay will be available until August 22, 2025, and investors can also access the live and archived webcast through the company's investor relations website.